当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 现金流量表

海尔生物

(688139)

  

流通市值:98.78亿  总市值:98.78亿
流通股本:3.16亿   总股本:3.16亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,888,678,735.241,250,361,495.99574,350,307.752,444,397,545.97
  收到的税费返还31,901,494.5322,665,711.9711,370,131.9338,320,562.76
  收到其他与经营活动有关的现金41,183,749.7723,396,106.1315,551,245.6554,358,007.79
  经营活动现金流入小计1,961,763,979.541,296,423,314.09601,271,685.332,537,076,116.52
  购买商品、接受劳务支付的现金898,801,815.11573,478,294.19274,950,369.931,193,137,579.66
  支付给职工以及为职工支付的现金519,829,842.29348,478,896.68185,693,586.39647,242,346.78
  支付的各项税费119,194,911.7182,046,652.258,510,149.45138,101,835.69
  支付其他与经营活动有关的现金237,560,967.73148,143,900.2970,440,352.21290,699,981.21
  经营活动现金流出小计1,775,387,536.841,152,147,743.36589,594,457.982,269,181,743.34
  经营活动产生的现金流量净额186,376,442.7144,275,570.7311,677,227.35267,894,373.18
二、投资活动产生的现金流量:
  收回投资收到的现金3,233,900,0001,954,760,000783,440,0003,955,764,141.17
  取得投资收益收到的现金22,714,361.4717,455,109.231,778,538.1622,067,445.89
  处置固定资产、无形资产和其他长期资产收回的现金净额100,83588,584.08100455,473.89
  收到的其他与投资活动有关的现金8,472,757.24---
  投资活动现金流入小计3,265,187,953.711,972,303,693.31785,218,638.163,978,287,060.95
  购建固定资产、无形资产和其他长期资产支付的现金51,911,088.1735,790,899.1215,578,197.98119,254,456.24
  投资支付的现金3,180,980,0001,794,190,000526,100,0003,785,640,000
  取得子公司及其他营业单位支付的现金---56,647,500
  支付其他与投资活动有关的现金1,590,8841,553,420--
  投资活动现金流出小计3,234,481,972.171,831,534,319.12541,678,197.983,961,541,956.24
  投资活动产生的现金流量净额30,705,981.54140,769,374.19243,540,440.1816,745,104.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金74,991,201.763,731,201.76-225,000
  其中:子公司吸收少数股东投资收到的现金74,991,201.763,731,201.76-225,000
  取得借款收到的现金10,000,00010,000,0005,000,00020,000,000
  收到其他与筹资活动有关的现金---717,966,461.12
  筹资活动现金流入小计84,991,201.7613,731,201.765,000,000738,191,461.12
  偿还债务支付的现金19,990,00010,010,0005,010,00010,010,000
  分配股利、利润或偿付利息支付的现金107,042,446.68105,778,234.17153,575.33150,295,702.61
  其中:子公司支付给少数股东的股利、利润3,480,588.882,286,500-2,938,276.5
  支付其他与筹资活动有关的现金37,638,535.673,668,255.221,469,892.73846,622,175.04
  筹资活动现金流出小计164,670,982.35119,456,489.396,633,468.061,006,927,877.65
  筹资活动产生的现金流量净额-79,679,780.59-105,725,287.63-1,633,468.06-268,736,416.53
四、汇率变动对现金及现金等价物的影响-10,504,104.59-8,907,018.78-7,434,796.113,199,531.7
五、现金及现金等价物净增加额126,898,539.06170,412,638.51246,149,403.3619,102,593.06
  加:期初现金及现金等价物余额553,806,623.74553,806,623.74553,806,623.74534,704,030.68
  期末现金及现金等价物余额680,705,162.8724,219,262.25799,956,027.1553,806,623.74
补充资料:
  净利润-148,915,536.8-255,132,280.57
  资产减值准备-2,239,082.03-8,507,764.46
  固定资产和投资性房地产折旧-36,981,509.15-71,800,978.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-36,597,186.65-71,032,333.78
    投资性房地产折旧-384,322.5-768,645
  无形资产摊销-24,337,800.45-48,373,937.95
  长期待摊费用摊销-1,087,642.91-2,328,495.2
  递延收益摊销--1,520,476--3,263,645.16
  处置固定资产、无形资产和其他长期资产的损失-102,532.28--632,148.71
  固定资产报废损失-63,671.06-1,225,721.96
  公允价值变动损失--2,224,070.28-494,110.38
  财务费用--471,146.53--21,561,678.65
  投资损失--5,829,691.33--27,308,983.33
  递延所得税--12,812,076.06--31,895,649.67
  其中:递延所得税资产减少--10,396,413.94--23,666,047.65
    递延所得税负债增加--2,415,662.12--8,229,602.02
  存货的减少-9,291,842.66--18,645,073.77
  经营性应收项目的减少--36,476,468.16--68,683,543.49
  经营性应付项目的增加--25,376,942.06-34,073,537.69
  现金的期末余额-724,219,262.25-553,806,623.74
  减:现金的期初余额-553,806,623.74-534,704,030.68
  现金及现金等价物的净增加额-170,412,638.51-19,102,593.06
公告日期2026-10-232026-08-202026-04-302026-03-28
审计意见(境内)标准无保留意见
TOP↑